An AI-powered due diligence software platform for science-based ventures, available in Microsoft Copilot, Claude and on the web.
Zetesis translates high-dimensional science, from omics and gene therapy to AI-driven discovery and advanced materials, into rigorous, referenced analysis for every capital commitment across the value chain.
Every assessment is source-linked, reproducible and digitally signed. Teams query it directly, and reassess it as the evidence changes: transparent diligence, structured exploration and risk mitigation in one platform.
Science, clinical and field performance, intellectual property, regulatory, manufacturing and commercial. Each has to hold. Zetesis integrates them into one assessment.
Method, replication, validation.
Endpoints, power, comparators, real-world performance.
Coverage, ownership, freedom to operate, pathway, precedent.
Scale-up, cost of goods, market assumptions, execution.
Zetesis works with venture firms, corporate venture arms, family offices, deep-tech funds and business development teams. Start on the platform today, or bring a live claim for a full assessment.
Request a charter engagement →